Development and evaluation of orally disintegrating tablets containing the mosapride resin complex
The purpose of this study was to prepare a mosapride citrate-resin (Amberlite® IRP 88) complex and orally fast-disintegrating tablets of the resin complex. The resinate complex of mosapride-Amberlite® IRP 88, mass ratio 2:1, was prepared in an ethanol-water solution. The effects of alcohol concentra...
Saved in:
Main Authors: | Wu Tong, Wang Guanhua, Shi Caihong, Li Jinghan, Zhao Na, Dong Zihao, Pan Weisan, Zhang Xiangrong |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2018-06-01
|
Series: | Acta Pharmaceutica |
Subjects: | |
Online Access: | https://doi.org/10.2478/acph-2018-0017 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risperidone oral disintegrating mini-tablets: A robust-product for pediatrics
by: El-Say Khalid M., et al.
Published: (2015-12-01) -
Quality assessment of furosemide tablet generics used in a teaching hospital in Nigeria
by: Abdurrahman Umar, et al.
Published: (2025-02-01) -
Tablet characteristics and pharmacokinetics of orally disintegrating tablets containing coenzyme Q10 granules prepared by different methods
by: Kashiwagura Yasuharu, et al.
Published: (2023-03-01) -
Influence of pH modifiers on the dissolution and stability of hydrochlorothiazide in the bi- and three-layer tablets
by: Blatnik Sandra Urek, et al.
Published: (2015-12-01) -
A dual strategy to improve psychotic patients’ compliance using sustained release quetiapine oral disintegrating tablets
by: Refaat Ahmed, et al.
Published: (2016-12-01)